Bronchodilation is a sympathetic response. When your sympathetic nervous system activates, it relaxes the smooth muscle surrounding your airways, widening them to let more air flow into your lungs. The parasympathetic nervous system does the opposite: it narrows your airways through bronchoconstriction. These two systems work against each other to control how open or closed your airways are at any given moment.
Why Sympathetic Activation Opens Your Airways
Bronchodilation is part of the body’s fight-or-flight response. When you face a physical threat or intense exertion, your sympathetic nervous system triggers a cascade of changes: your heart rate climbs, your pupils dilate, blood diverts from your digestive organs to your muscles, and your airways widen. All of this prepares your body for explosive physical action, and wider airways mean more oxygen reaches your bloodstream faster.
The primary chemical driver is adrenaline (epinephrine), which is the most potent natural activator of the receptors on airway smooth muscle called beta-2 receptors. Noradrenaline (norepinephrine) also activates these receptors, but with a weaker effect. When adrenaline binds to a beta-2 receptor, it kicks off an intracellular chain reaction: an enzyme produces a signaling molecule called cAMP, which triggers proteins that lower calcium levels inside smooth muscle cells. Since calcium is what makes muscle cells contract, reducing it causes the muscle to relax and the airway to open up.
Interestingly, most of the sympathetic bronchodilation in humans comes not from nerve signals directly reaching the airway muscles, but from adrenaline circulating in the blood after being released by the adrenal glands. The sympathetic nerves in the lungs play more of an indirect role, moderating how strongly the parasympathetic signals constrict the airways rather than relaxing the muscle on their own.
How Parasympathetic Signals Narrow Airways
The parasympathetic nervous system is the dominant neural controller of airway diameter. Parasympathetic nerve fibers from the vagus nerve release acetylcholine, which binds to M3 muscarinic receptors on bronchial smooth muscle. This triggers contraction, narrowing the airways. It also stimulates mucus secretion into the airway lumen. Together, these actions reduce airflow and represent the body’s “rest and digest” state, where maximum oxygen intake is not a priority.
At rest, your airways maintain a baseline level of narrowing called bronchomotor tone, which is largely set by ongoing parasympathetic activity. This means your airways are always somewhat constricted by default, and bronchodilation occurs when either sympathetic signals ramp up or parasympathetic signals dial down. This is why drugs that block acetylcholine’s action on M1 and M3 receptors can open airways just as effectively as drugs that mimic adrenaline, though through a completely different mechanism.
A Third Pathway That Doesn’t Fit Either Category
The sympathetic and parasympathetic systems aren’t the whole story. A third set of nerves, called non-adrenergic non-cholinergic (NANC) nerves, can also relax airway smooth muscle. These nerves don’t use adrenaline or acetylcholine. Instead, they appear to use signaling molecules like nitric oxide and certain neuropeptides. When researchers blocked both the standard sympathetic and parasympathetic pathways in experiments and then stimulated the vagus nerve, they still observed pronounced bronchodilation, proving this third system operates independently.
In humans, irritation of the larynx or inhalation of certain irritants can trigger a brief NANC bronchodilator response even when the usual nerve pathways are pharmacologically blocked. The exact neurotransmitter responsible hasn’t been conclusively identified, but nitric oxide is a strong candidate.
How Medications Use These Pathways
The two main classes of inhaled bronchodilators map directly onto this sympathetic-versus-parasympathetic framework. Beta-2 agonists (like albuterol) mimic what your sympathetic system does naturally. They bind to the same beta-2 receptors that adrenaline targets, triggering the same cAMP cascade that relaxes airway smooth muscle. Fast-acting versions start working in one to three minutes.
Anticholinergic bronchodilators take the opposite approach. Instead of activating the sympathetic side, they block the parasympathetic side by preventing acetylcholine from binding to muscarinic receptors. Since resting airway tone is driven by parasympathetic activity, blocking that input lets the airways relax. Selectively blocking M1 and M3 receptors provides the most effective relief, because those subtypes are responsible for bronchoconstriction and mucus secretion.
Both strategies end in the same result: wider airways. But they get there through different mechanisms, which is why they’re sometimes used together in conditions like COPD, where combining both approaches provides better airway opening than either one alone.
The Quick Summary of Which System Does What
- Sympathetic nervous system: releases adrenaline, activates beta-2 receptors, relaxes airway smooth muscle, causes bronchodilation
- Parasympathetic nervous system: releases acetylcholine via the vagus nerve, activates M3 muscarinic receptors, contracts airway smooth muscle, causes bronchoconstriction and increased mucus secretion
- NANC system: uses nitric oxide and neuropeptides independently of both main pathways to produce additional bronchodilation